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Abstract: Parenteral nutrition (PN) is a complex and specialized form of nutrition support that
has revolutionized the care for both pediatric and adult patients with acute and chronic intestinal
failure (IF). This has led to the development of multidisciplinary teams focused on the management of
patients receiving PN: nutrition support teams (NSTs). In this review we aim to discuss the historical
aspects of IF management and NST development, and the practice, composition, and effectiveness of
multidisciplinary care by NSTs in patients with IF. We also discuss the experience of two IF centers as
an example of contemporary NSTs at work. An NST usually consists of at least a physician, nurse,
dietitian, and pharmacist. Multidisciplinary care by an NST leads to fewer complications including
infection and electrolyte disturbances, and better survival for patients receiving short- and long-term
PN. Furthermore, it leads to a decrease in inappropriate prescriptions of short-term PN leading to
significant cost reduction. Complex care for patients receiving PN necessitates close collaboration
between team members and NSTs from other centers to optimize safety and effectiveness of PN use.
Keywords: nutrition support team; intestinal failure; parenteral nutrition
1. Introduction
Intestinal failure (IF), first defined in 1981 as “a reduction in the functioning gut mass below
the minimal amount necessary for adequate digestion and absorption of food” [1], is characterized
by dependence on parenteral nutrition (PN). IF can be an acute self-limiting condition (type I),
a prolonged acute condition requiring short-term PN for weeks or months (type II), or a chronic
condition requiring long-term PN for months or years (type III) [2,3]. Chronic IF has different etiologies
(see Table 1), but the most common cause in both adults and children is short bowel syndrome (SBS)
as a consequence of extensive small bowel resection, followed by intestinal motility disorders and
congenital enteropathies [4,5]. Specialized nutrition therapy is the corner stone of management of IF
patients. The administration of macronutrients, micronutrients, fluids, and electrolytes can be given
enterally via oral and tube feeding, and parenterally via a central venous catheter (CVC) or shunt.
The enteral route is the optimal and most physiologic route of feeding and should always be extensively
considered before PN is initiated. Feeding via the enteral route stimulates bowel adaptation and
decreases the risk of IF-associated liver disease. If possible, patients should be fed orally since this
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prevents food aversion disorders, promotes epidermal growth factor release from the salivary glands,
and increases gastrointestinal secretion of trophic factors [6]. Nutritional support is highly complex and
several reports show that physicians are insufficiently trained and experienced to offer the necessary
nutrition support [7–9]. This is also reflected in the current rudimentary role of nutrition education in
medical training [10,11]. There are some clinical trials involving nutrition strategies in the pediatric
and adult intensive care unit [12,13], but for patients receiving long-term PN, clinical practice is mostly
based on experience and expert opinion [3]. Therefore, it is important that clinicians from different
disciplines with expertise in IF collaborate in a nutrition support team (NST) to prevent complications
and improve outcome. In this review we aim to discuss the historical aspects of IF management and
NST development, and the role, composition and effectiveness of an NST in the management of adult
and pediatric IF patients, with a focus on patients receiving long-term PN. Finally, we discuss the
experience of our IF centers as an example of current practice in NSTs.
Table 1. Common causes of intestinal failure in adults and children, adapted from [4,5].
Adults Children
Cause Underlying Diseases Cause Underlying Diseases
Short bowel syndrome
(extensive bowel
resection)
• Crohn’s disease
• Mesenteric infarction
• Radiation enteritis
Short bowel syndrome
(extensive bowel
resection or congenital)
• Necrotizing enterocolitis
• Midgut volvulus
• Intestinal atresia
• Gastroschisis
Intestinal motility
disorder
• Chronic intestinal
pseudo-obstruction
syndrome
(primary/secondary)
Intestinal motility
disorder
• Pediatric intestinal
pseudo-obstruction syndrome
• Hirschsprung’s disease with
involvement of small bowel
Congenital enteropathy • See underlyingdiseases in children Congenital enteropathy
• Microvillus atrophy
• Intestinal epithelial dysplasia
• Tricho-hepato-enteric syndrome
• Autoimmune enteropathy
Intestinal fistula
• Iatrogenic
• Inflammatory
• Neoplastic
• Infectious
• Trauma
Mechanical obstruction
• Intraluminal
• Intrinsic
bowel lesions
• Extrinsic lesions
2. General Management of Intestinal Failure Patients
At baseline, a comprehensive nutritional assessment is required to determine the hydration
and nutritional status of a patient with IF and to calculate individual requirements. This nutrition
assessment should incorporate aspects influencing intake, absorption, and expenditure, such as sex
and age, the anatomy of the intestine (i.e., remaining bowel length, enterostomies, presence of ileocecal
valve), and weight, height, and body composition. For visual representation see Figure 1, a more
detailed description of the individual components is provided in Table 2 [14–25]. The assessment
should be repeated regularly to evaluate the effectiveness of a nutrition intervention and to prevent
patients from becoming dehydrated and undernourished with associated electrolyte abnormalities and
weight loss. Especially in children, recurrent evaluation is essential to prevent growth deteriorations
and to assess the adaptation response of the bowel and to increase enteral feeding and wean from PN
to prevent excessive provision of calories [4,20].
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Figure 1. Nutrition assessment for intestinal failure patients on parenteral nutrition. This is a visual
sum ary of the components described in ore detail in Table 2.
The route, type, and duration of nutritional support depends on the patient, underlying disease,
and stage of IF. In SBS, there are three clinical phases after surgery: the acute phase, adaptation phase,
and maintenance phase, correspon i it iff r t trition strategies [26,27].
The acute phase, directly f ll i , is characterized by exclusive PN adminis ration in
a hospital setting. The intesti r adapt, and hydration and nu ritional status can be
restored. In the adaptation i ate goal of treatment is to increase enteral nutrition (EN)
and wean from PN, since P is i t it frequent complication such as IF- and PN-associated
liver disease, central line-associated blood stream infections (CLABSIs), central line occlusions, central
line-related thrombosis, metabolic bone disease, and fluid/electrolyte problems [28]. The maintenance
phase reflects a period of stabilization. In some patients, enteral autonomy (i.e., being independent of
PN) is achieved in hospital, others are discharged on home PN (HPN) when they are clinically stable.
HPN can be indicated for patients with irreversible IF or for children who are expected to be dependent
on PN for at least three months [27,29,30]. Patients with a longer residual small bowel, a younger
age at intestinal resection, preservation of the ileocecal valve, necrotizing enterocolitis, absence of
severe liver disease, and normal gastrointestinal motility have a greater chance of weaning off PN and
achieving enteral autonomy, although it remains difficult to predict [31].
3. The Composition of a Nutrition Support Team
Each patient with IF that is malnourished, or at risk of becoming malnourished, will need artificial
nutritional support in the form of EN and/or PN. The management of this nutritional support should
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be guided by an NST to improve quality of care [32]. The concept of an NST is not new. The first
report of an NST was in 1972, set up to organize nutritional support better because of concerningly
high sepsis rates in hospitalized patients on PN [33]. This was four years after the first use of PN in
human, but before the first definition of IF (see Figure 2) [1,33–37]. In 1974, Butterworth described
physician-induced malnutrition and the need to appreciate the role of nutrition in determining the
outcome of illness for many patients in “The skeleton in the hospital closet.” This publication is
nowadays seen as the cradle of nutrition teams [38]. An NST was described in 1992 in a report that led
to the formation of the British Association for Parenteral and Enteral Nutrition (BAPEN) [39]: “A team
of different disciplines with good communication enables nutritional support to be given in the best
manner for each patient. Such a team improves the quality of treatment and reduces costs by: Avoiding
unnecessary treatments and simplifying the treatments used; reducing complications; monitoring
use of nutrients and outcome of treatment; reducing waste (for example, solutions prepared but not
given or only partially used); standardizing nutrients and equipment to enable bulk purchase and
negotiation of competitive rates”. A recently published review that thoroughly discusses the tasks,
composition, and efficacy of NSTs in hospital for malnourished patients admitted to hospital shows
favorable effects of nutritional support by NSTs [40].
Table 2. Components of nutrition assessment for patients with intestinal failure.
Component Description
Dietary history
and fluid balance
Detailed information about previously tried diets including route, amount, and type of
nutrition/formula with reasons for lack of success, and measurement of current fluid balance is
required for designing a new individualized feeding regimen.
Anatomy of
intestine
It is important to document the anatomy and function of the intestine or remaining intestine.
Most nutrients are absorbed in the first part of the jejunum. In case of jejunum resection, the residual
ileum is able to adapt and to partly take over the role of the jejunum in nutrient absorption.
However, when the terminal ileum is resected, the reabsorption of vitamin B12 and bile salts cannot
be replaced by jejunal cells. Resection of the ileocecal valve decreases intestinal transit time and
supposedly predisposes to reflux of colonic content (including higher bacterial counts) back into the
small intestine. Dysmotility and/or dilated loops cause intestinal stasis leading to SIBO,
which negatively impacts the digestion and absorption of nutrients. [14]. High-output stomas may
cause water, sodium, and magnesium depletion [15].
Energy
requirements,
anthropometrics,
sex and age
Energy requirements are preferably measured by indirect calorimetry. If this is not possible, these
requirements should be calculated based on body weight, height, sex, and age, and adjusted
accordingly by patient response (i.e., when not gaining weight as expected). To measure the effect of
a nutritional intervention, anthropometrics should be monitored with growth charts in pediatric
patients. Next to weight and height, it is also recommended to assess and monitor body
composition (with for example air-displacement plethysmography) and muscle function (with for
example handgrip strength). In a recent study in pediatric IF patients receiving long-term PN,
Neelis et al. reported that these children had higher fat mass and lower fat-free mass (i.e., muscle,
water, bone, and internal organs), compared with healthy peers [16]. In another study, involving
adult IF patients, it was shown that 73% had sarcopenia (i.e., loss of muscle mass and function) [17].
Biochemistry:
electrolytes and
micronutrients
Micronutrient deficiencies are common in IF patients [18,19]. Electrolytes such as sodium and
magnesium may be low due to excessive gastrointestinal losses, whereas calcium, phosphate and
potassium can be elevated as a consequence of dehydration [20]. Screening of electrolytes, vitamins,
and trace elements should be performed at baseline and monitored thereafter. Electrolytes should be
monitored every 1–3 months or more frequently when indicated (e.g., in the case of recent PN
composition change or increased gastro-intestinal losses); vitamins and trace elements should be
monitored every 6–12 months [21,22].
Medication
Some medication may increase intestinal losses (e.g., non-steroidal anti-inflammatory drugs, proton
pump inhibitors, antibiotics) [23]. Proton pump inhibitors are frequently used to reduce gastric PH
and gastric fluid production which is most markedly increased in the hypersecretory acute phase of
IF [24]. Also, because of the decreased enteral absorption of nutrients and fluids by the small
intestine, medication dosages may have to be adjusted or converted to intravenous supplementation.
If it is uncertain whether the medication will be enterally absorbed, the intravenous route is the
preferred one [25].
IF: intestinal failure, PN: parenteral nutrition, SIBO: small intestinal bacterial overgrowth.
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In current society guidelines for both adults and children ith IF, the anage ent of P
patients by an NST in centralized units is recommended by the ESPGHAN, ESPEN, ESPR, CSPEN,
ASPEN, and AuSPEN [3,21,41–45]. In general, the structure and function of NSTs varies among
institutions and depends on the local needs, available funding, organizational culture, and available
personnel [46]. In specialized IF centers, the composition of the team also differs, as was shown in an
international survey on pediatric IF teams. Of the 61 participating teams from 20 different countries the
teams consisted of a pediatric gastroenterologist (present in 100% of the teams), dietitian (95%), nurse
specialist (92%), pediatric surgeon (89%), pharmacist (82%), psychologist (66%), social worker (62%),
speech therapist (48%), physiotherapist (38%), and general pediatrician (33%) [47]. For adults on HPN,
the core members of an NST should be a physician, nutrition nurse specialist, senior dietitian, and senior
clinical pharmacist, according to the ESPEN guidelines [43]. In Table 3 a suggestion for the composition
of an NST for both pediatric and adult patients on HPN is given including the minimal designated
roles of each team member [32,43,46,48,49]. The goal of an NST should be to provide both physical
and psychological support for patients on HPN and their caregivers. The attention for psychological
aspects is important, since HPN is known to adversely affect the quality of life and everyday problems
such as the inability to work or to go to school or the inability to go on a holiday [50,51]. The tasks of the
team are aimed at preventing and treating malnutrition, monitoring and evaluating nutrition therapy,
and minimizing, managing, and auditing complications of EN and PN [43]. It should be emphasized
that through interdisciplinary cross training, expertise, and experience of the suggested roles in Table 3
may vary between disciplines. For example, a clinical pharmacist might fulfill components of the roles
of a dietitian, or a nurse may also have an expanded role including tasks of the supervising physician
of the NST. Interdisciplinary cross training and the variation of tasks within the teams is essential to
allow for safe practice in the absence of individual team members.
4. Improved Outcomes with Nutrition Support Teams
Several studies describe the effect of NSTs for patients suffering from IF on a variety of clinical
outcomes which are summarized below. Studies were identified by performing an extensive search in
PubMed in July 2019. Keywords included: intestinal failure, parenteral nutrition, multidisciplinary
care (team), nutrition support (team), and intestinal rehabilitation program. Studies were included if
they discussed the effects of a nutrition support team on patients receiving PN for IF. Furthermore,
reference lists from relevant (review) articles were screened for studies missed in the primary search;
relevant articles were included if they met the inclusion criteria.
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Table 3. Suggested members of a nutrition support team for patients on home parenteral nutrition and
their minimal designated roles [32,43,46,48,49].
Core Members Roles
Supervising physician *
Supervision and overall responsibility of care provided by the team
Understands underlying diseases and prognosis
Prescribes PN solutions and medication
Gastroenterologist * Understands and treats underlying diseases(Aids in) operative insertion of gastrostomies/jejunostomies
Surgeon *
Operative insertion of CVCs and gastrostomies/jejunostomies
Surgical management of IF (e.g., restoration of bowel continuity, surgical
lengthening procedures, and management of anastomotic strictures)
Is responsible for postsurgical care
Interventional radiologist */
Anesthesiologist *
Assists in challenging pediatric cases of central venous access. In adults,
interventional radiologists are the primary consultant regarding CVC
placement.
Nurse specialist *
Teaches and trains patients and/or caregivers in care of tubes, stomas,
and CVCs and in home PN administration when applicable
Recognizes and manages complications of CVCs etc.
Is case manager for patients and their caregivers
Dietitian *
Conducts nutritional screening and assessment
Designs and implements feeding regimens based on measurement or
calculation of individual requirements
Monitors patient’s response with nutritional, laboratory, and fluid status
Is case manager for patients and their caregivers
Pharmacist *
Is responsible for providing enteral formulations and PN solutions and for
composition optimization
Advises on compatibility and stability issues and drug/nutrient interactions
Additional Members Roles
Endocrinologist *
Advises on preventing and treating complications of PN (and malnutrition)
such as growth problems in children, metabolic bone disease, osteoporosis,
and diabetes mellitus
Hematologist * Advises on prevention and treatment of catheter-related thrombosis
Psychologist * Provides psychological support and therapy for patients (and caregivers)
Speech therapist * Advises on oral feeding in case of oral aversion or swallowing difficulties
Social worker * Provides emotional support for patients (and caregivers)
Physiotherapist * Assesses motor development in pediatric patientsProvides training programs focused on weight-bearing exercise
CVCs: central venous catheters, PN: parenteral nutrition. * If the nutrition support team cares for pediatric patients,
this team member should be trained in pediatric medicine.
4.1. Complications in Adults Receiving Parenteral Nutrition
As stated in Section 2, patients with IF are at risk of various complications, which can be related to
the underlying intestinal disease, PN administration through a central venous catheter, or a combination
of both, which can lead to significant morbidity and mortality [28]. The initiation of an NST has proven
beneficial in the reduction of numerous complications in multiple studies as specified below.
As early as 1980, a decrease in complication rate was seen in a group of hospitalized adult patients
receiving PN managed by an NST compared with a group managed by a variety of physicians [52].
Braun et al. retrospectively assessed the effect of initiation of an NST among hospitalized adult
patients receiving PN. The NST consisted of a physician (gastrointestinal focused), two registered
dietitian nutritionists, a registered nurse and a nutrition support pharmacist. Mortality decreased
after the initiation of the NST (12.7 vs. 10.6%, p = 0.012). Furthermore, they reported fewer electrolyte
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disturbances after the implementation of the NST (53%; χ2 = 10.906, p = 0.004). Also, the authors
reported on significantly less usage of potassium, phosphorus, and magnesium intravenous piggyback
supplementation (88.8 vs. 94%; χ2 = 5.05, p = 0.026) [53].
A retrospective comparative study by Chong et al. on adult patients solely receiving PN in
hospital showed a marked decrease in electrolyte disturbances after the initiation by the NST. The NST
was led by a surgeon and included a surgical medical officer, a surgical ward pharmacist, a parenteral
nutrition pharmacist, a dietician, and a nurse. Length of hospital stay, mortality, and duration of PN
were similar prior and after initiation of the NST [54].
A systematic review by Naylor et al. published in 2004 included five studies (n = 489 patients)
that reported on the effects of a total parenteral nutrition (TPN) team on metabolic and electrolyte
abnormalities in adults receiving short-term PN in hospital [55]. Four studies (n = 420 patients)
reported fewer abnormalities in patients managed by a TPN team (members of the teams varied
between studies) [56–59]. One study (n = 69 patients) did not report a significant difference in the total
number of abnormalities [60].
The positive effect of an NST on CLABSIs was observed in 78 adult patients who received PN on
a surgical ward. NST consisted of a nutritional nurse (other members were not reported). Jacobs et al.
describe a decrease from 24 to 3% in their cohort after initiation of an NST (p < 0.05) [59]. A study
performed in a tertiary hospital in Michigan investigated patients receiving PN on wards where service
of an NST was mandatory versus patients receiving PN on wards without an NST. CVC longevity was
longer in units where NST consultation was mandatory (mean 20.4 days versus 14.4 days) [61].
Kennedy et al. also reported on the effect of an NST for adult patients receiving PN. After initiation
of the NST mortality for patients receiving PN decreased from 43 to 24% (p = <0.05). Calculated cost
savings was 50.715 British pounds in one year [62].
In conclusion, several retrospective studies report that in hospitalized adult patients receiving
short-term PN an NST results in fewer electrolyte disturbances, complications not otherwise defined,
CLABSI and mortality. These findings demonstrate that PN administration is not risk free and
potentially lethal and should therefore be monitored by an NST. Since the cohorts of investigated
patients differ between studies, and outcomes differ between studies, no meta-analysis of the results
was possible.
4.2. Complications in Children Receiving Parenteral Nutrition
A Polish study published the effects of an NST on the prevalence of CLABSI in 27 children
(age 2–48 months) receiving PN in hospital for a mean duration 219 days. 48% of the children suffered
from a motility disorder, 37% had SBS. The study showed a decrease from 11.5 CLABSIs per 1000
catheter days prior NST to 1.1 CLABSIs per 1000 catheter days after NST initiation. Authors did not
report on an effect on mortality [63].
Diamond et al. reported on the effect of a multidisciplinary team for children with SBS
that included representation from surgery, neonatology, gastroenterology, transplantation, nursing,
nutrition, pharmacy, social work, and palliative care. Children experienced significantly fewer overall
episodes of sepsis per month of follow-up after implementation of the multidisciplinary team (0.3 vs.
0.5, p = 0.01). Other complications and mortality did not differ between the group before and after
implementation of the multidisciplinary team [64].
The development of an advanced nutrition team for neonates with SBS (composed of professionals
from gastroenterology, neonatology, general surgery, nursing, nutrition, pharmacy, social work,
and occupational therapy) resulted in a decrease in mortality (14.8 versus 7.1%, p = 0.362) [65].
Modi et al. saw a similar effect on the survival in pediatric patients with severe SBS cared for by a
multidisciplinary team compared to a historical control group with overall survival increasing from 70
to 89% (p < 0.05). No significant difference in weaning from PN was observed. The team consisted of
dedicated pediatric staff in general surgery, gastroenterology, transplant surgery, nutrition, pharmacy,
nursing, and social work [66].
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Hess et al. also retrospectively identified the effect of a comprehensive clinical care team (pediatric
surgeons, pediatric gastroenterologists, nutritionists, nurses, and pharmacologists) on mortality after
2 years of diagnosis in children with IF (underlying disease distribution not reported) (29.4 to 6.7%,
p = 0.011) [67].
Oliveira et al. reported on reduced disease-related mortality after installation of a multidisciplinary
intestinal rehabilitation program for children diagnosed with IF between 0–365 days with 0.6 deaths
per 3 months (95% CI −1.23–0.02). No significant effect on CLABSIs or advanced liver disease was
reported [68].
Multivariate analysis showed a hazard ratio of 5.6 for risk of death if an adult patient was cared
for by an inexperienced HPN team compared to an experienced HPN team. In children a hazard ratio
of 2.5 for risk of death was observed if a nutritional care team was absent during management [27].
A meta-analysis including 233 children performed by Stanger et al. in 2013 examining on the effect
of multi-disciplinary rehabilitation programs for children with IF also found an increase in overall
patient survival (RR = 1.22, 1.04–1.42, p = 0.005) [69].
In short, in pediatric patients receiving PN, an NST results in fewer CLABSIs, overall episodes of
sepsis, and lower mortality across various studies. The increased survival rate as a consequence of an
NST differs between studies but is high.
4.3. Prescription of Parenteral Nutrition
Several studies report on a reduction of inadequate use of PN after implementation of an NST.
A reduction in the number of adult patients receiving short-term PN in both ICU and acute floor of a
tertiary referral hospital and level 1 trauma center was observed by Parent et al. (RR, 0.64; 95% CI,
0.53–0.77 and RR, 0.80; 95% CI, 0.64–0.99, respectively). The rate of patients with short-duration PN
use (PN duration of <5 days) declined by 30% in the ICU (RR, 0.70; 95% CI, 0.51–0.97). No data on
mortality or clinical outcomes were reported [70].
Another study reported a reduction in TPN use in critically ill adult patients of up to 78.6% after
implementation of an NST. Also less PN bags were wasted (493 versus 34) and yearly costs for PN
were decreased from $513,246 to 195,176 [8].
Lee et al. reported that after initiation of an NST for adult patients receiving EN and/or PN for
at least 72 h a higher percentage of goal energy (kcal) and protein (gram) provision was achieved
(66.9 versus 86.2% and 67 versus 81.7% respectively). Goal energy and protein was calculated based
on weight. Also, a decrease in days on PN and EN was observed. NST consisted of a physician,
pharmacist, nurse, and dietician [71].
Piquet et al. reported that initiation of an NST in a university hospital resulted in a 35% decline in
PN use with a parallel increase of EN. Furthermore, the amount of CLABSIs decreased from 25/year to
3/year (p = not reported). It was shown that the reduction in PN use and complications represented
savings of 245.000 euro/year [72]. The observed decrease of PN usage is only seen in acute hospital
setting and not observed when patients with chronic IF are treated by a multidisciplinary treatment
team. A meta-analysis of three studies (n = 233 children [64,66,73]) in children with chronic IF due to
SBS did not show an increase in the number of patients weaned from PN after implementation of a
multidisciplinary pediatric IF team (RR = 1.05, 0.88–1.25, p = 0.62) [69].
In conclusion, an NST results in fewer short-term PN prescriptions for adult patients admitted
to hospital resulting in significant cost saving. This effect is not described in children receiving
long-term PN.
4.4. Discussion
It is shown that the initiation of an NST is associated with a decrease in mortality and in mechanical,
septic, and metabolic complications for both pediatric and adult patients receiving either short- or
long-term PN, and results in more appropriate PN prescription for adult patients receiving short-term
PN. However, several methodological limitations of studies investigating the effect of NSTs should be
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taken into account. First, the majority of studies concerning NSTs are retrospective studies comparing
a cohort of patients prior and post initiation of an NST. This imposes a significant risk of bias. Since
two different time periods are compared, the observed effect cannot fully be attributed to the initiation
of the NST. For instance, with improved catheter care and the advent of new lipid emulsions survival
of patients has improved over time [28,74]. It should be noted that most improvements in care have
been developed and researched by (members of) NSTs, however this review discusses the direct effect
of an NST on patient care. Furthermore, several included studies have been published in the previous
century. Therefore, the described effect of NSTs should be interpreted with caution. An idea for future
research is to conduct multicenter prospective studies comparing the outcomes in patients with IF for
different compositions of NSTs since there is a lot of variation in this composition between centers.
5. Experience of Two Dutch Intestinal Failure Nutrition Support Teams
The NSTs of the Amsterdam UMC Emma Children’s hospital and the Erasmus Medical Center
Sophia Children’s hospital are embedded in an intestinal rehabilitation program (IRP). An IRP is an
extended version of an NST for patients with IF which provides care with the goal to promote intestinal
adaptation and to achieve enteral autonomy and oral feeding [75].
The multidisciplinary IF teams of Amsterdam and Rotterdam provide care for pediatric patients
with chronic IF on HPN, and the team of Amsterdam also for adult patients with both acute
and chronic IF. The teams consist of nurses, nurse specialists, a physician assistants, a pediatric
gastroenterologist, a gastrointestinal surgeon, pediatric surgeons, an endocrinologist, dietitians,
a pharmacist, a pediatric hematologist and a PhD student. Several other specialists, such as interventional
radiologists, gastroenterologists for adults, speech therapists, social workers, psychologists and pediatric
endocrinologists are consulted regularly. Approximately 115 adults suffering from type 3 IF and around
80 adults suffering from type 2 IF, and 65 children on HPN are managed by the teams. Also children
and adults that have weaned off HPN are followed up by the teams.
For children, all patients/caregivers are trained in safely caring for the CVC and PN in hospital,
prior to discharge with HPN. Adults are trained by homecare nurses. The IRP assesses the competence
of the trained adult patient and determines whether homecare can be discontinued. Patients on HPN
are seen at least twice a year at the outpatient clinic (in the first year after discharge more frequently).
The outpatient consult is multidisciplinary, patients are seen by a physician, nurse, and/or a dietitian.
In between outpatient consultations, patients are often seen in shared care by a general pediatrician,
have phone consultations, give regular updates via email (for example the current weight of the patient)
and can be seen earlier when indicated. Patients suffering from type 2 IF are seen every 6–8 weeks to
determine optimal timing of reconstructive surgery.
The IF teams of both Amsterdam and Rotterdam are easily accessible, 24 h per day. Parents and
adult patients can contact the team for PN delivery, feeding strategies, recipes or clinical assessment.
The PN solutions are delivered by the hospital pharmacy (tailor made PN) or by a facility company
(standard bags prepared or unprepared).
Monitoring of HPN patients involves medical and psychosocial evaluation. Annual screening
includes physical examination, dietetic review, assessment of growth and body composition (with
air-displacement plethysmography), laboratory monitoring (electrolytes, full blood count, kidney and
liver function tests, coagulation profile, vitamin levels and trace elements), bone health (with hand
X-ray and dual-energy X-ray absorptiometry (DXA), physical activity assessment), IF associated liver
disease (with abdominal ultrasound and/or liver transient elastography (FibroScan)) and renal disease,
dental review, endocrinological assessment, and, additional for pediatric patients, consultation of a
speech therapist, physiotherapist, and social worker.
Twice a week, a multidisciplinary briefing takes place in which admitted patients and patients
seen at the outpatient clinic are discussed. The pediatric IF team can be consulted by the clinicians
from pediatric clinical wards if a patient is on PN for two weeks or more and not growing adequately.
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Adult patients from adult clinical wards including ICU are discussed on a weekly basis in the
multidisciplinary nutrition team clinical round.
The close collaboration between the teams of Amsterdam and Rotterdam enables the discussion
of difficult cases and collaboration on research topics. Also, the two remaining IF centers from The
Netherlands, being Nijmegen and Groningen (the latter is the national intestinal transplantation center),
are involved in this collaboration. Twice a year, the four teams come together to discuss clinical practice
and ongoing studies. For optimization of care, members of both IF teams are involved in research
projects, development of international guidelines, and attend national and international conferences.
These conferences provide the teams the opportunity to present their study findings, to keep up to date
on the management of IF, to work on team building, and to start and maintain collaborations in research
with other IF centers from all over the world. Both teams are involved in the recently established
European Reference Network for rare Inherited and Congenital Anomalies (ERNICA)—Intestinal
Failure working group. Since IF is a rare disease, international collaboration is vital to improve care
through research.
6. Conclusions
The care for both children and adults with IF is complex and requires expertise from different
disciplines. Nutrition is the cornerstone of treatment in these patients that are dependent on short-
or long-term PN. Clinicians should work together in an NST, consisting of at least a supervising
physician (e.g., gastroenterologist, endocrinologist, and/or surgeon), nurse or nurse specialist, dietitian,
and pharmacist. NSTs support the improvement of outcomes concerning survival, electrolyte
disturbances, and infections. Also, NSTs lead to a decrease in the inappropriate prescription of
short-term PN. Prospective multicenter studies are needed to improve the quantity and quality
of evidence concerning outcomes with NSTs in IF patients. Close collaboration between team
members and also between IF centers is crucial in the management of patients with this rare and
complicated condition.
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